Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sinovac Biotech (SVA)
NASDAQ:SVA
Holding SVA?
Track your performance easily
SVA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.25 - $6.58
Previous Close$6.47
VolumeN/A
Average Volume (3M)8.23K
Market Cap
N/A
Enterprise Value-$7.15B
Total Cash (Recent Filing)$11.22B
Total Debt (Recent Filing)$298.98M
Price to Earnings (P/E)―
BetaN/A
Next Earnings
May 05, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.31
Shares Outstanding71,139,402
10 Day Avg. Volume0
30 Day Avg. Volume8,227
Standard Deviation0.06
R-Squared0.04
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-26.81
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sinovac Biotech News
PremiumCompany Announcements
Sinovac Biotech Experiences 2024 Mid-Year DownturnPremiumCompany Announcements
Sinovac Biotech Embraces Post-Pandemic Challenges
Ownership Overview
―
Insiders
0.04% Mutual Funds
20.76% Other Institutional Investors
79.20% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
SVA FAQ
What was Sinovac Biotech’s price range in the past 12 months?
Sinovac Biotech lowest stock price was $6.25 and its highest was $6.58 in the past 12 months.
What is Sinovac Biotech’s market cap?
Currently, no data Available
When is Sinovac Biotech’s upcoming earnings report date?
Sinovac Biotech’s upcoming earnings report date is May 05, 2025 which is in 134 days.
How were Sinovac Biotech’s earnings last quarter?
Sinovac Biotech released its earnings results on Aug 16, 2024. The company reported -$0.08 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.08.
Is Sinovac Biotech overvalued?
According to Wall Street analysts Sinovac Biotech’s price is currently same.
Does Sinovac Biotech pay dividends?
Sinovac Biotech does not currently pay dividends.
What is Sinovac Biotech’s EPS estimate?
Sinovac Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sinovac Biotech have?
Sinovac Biotech has 71,860,700 shares outstanding.
What happened to Sinovac Biotech’s price movement after its last earnings report?
Sinovac Biotech reported an EPS of -$0.08 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Sinovac Biotech?
Currently, no hedge funds are holding shares in SVA
---
Sinovac Biotech Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-1.44%
Trailing 12-Months
Asset Growth
-6.03%
Trailing 12-Months
Company Description
Sinovac Biotech
Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.
---
Technical Analysis
---